SMS Lifesciences India Limited
Haleos Labs Limited engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India. The company offers API and intermediates in areas, such as anti-ulcer, anti-migraine, anti-hypertensive, erectile dysfunction, anti-cancer, antifungal, anti-obesity, anti-emetic, anti-depressant, anti-worm, anti-infective, anti-gout, anti-convulsant, antiviral, and anesthesia, a… Read more
SMS Lifesciences India Limited (SMSLIFE) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of March 2025: 0.161x
Based on the latest financial reports, SMS Lifesciences India Limited (SMSLIFE) has a cash flow conversion efficiency ratio of 0.161x as of March 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₹340.55 Million) by net assets (₹2.12 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
SMS Lifesciences India Limited - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how SMS Lifesciences India Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
SMS Lifesciences India Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of SMS Lifesciences India Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Swiftmerge Acquisition Corp
NASDAQ:IVCP
|
0.070x |
|
PT Surya Esa Perkasa Tbk
STU:71S
|
0.042x |
|
Moadata Co. Ltd.
KQ:288980
|
-0.039x |
|
ZINC MEDIA GR. LS -00125
F:YE42
|
N/A |
|
TGLT S.A
PINK:TGLTY
|
0.952x |
|
Wenzhou Kangning Hospital Co. Ltd
F:4WK
|
0.058x |
|
ELTON S.A. NAM. EO 052
F:Y1O
|
N/A |
|
Lotte Chemical Titan Tbk PT
JK:FPNI
|
0.000x |
Annual Cash Flow Conversion Efficiency for SMS Lifesciences India Limited (2016–2025)
The table below shows the annual cash flow conversion efficiency of SMS Lifesciences India Limited from 2016 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | ₹2.12 Billion | ₹298.10 Million | 0.141x | +12.00% |
| 2024-03-31 | ₹1.94 Billion | ₹243.06 Million | 0.126x | +14010783.13% |
| 2023-03-31 | ₹1.64 Billion | ₹1.47K | 0.000x | +100.00% |
| 2022-03-31 | ₹1.65 Billion | ₹-112.41 Million | -0.068x | -125.04% |
| 2021-03-31 | ₹1.29 Billion | ₹351.70 Million | 0.272x | +116.54% |
| 2020-03-31 | ₹1.16 Billion | ₹145.47 Million | 0.126x | -55.44% |
| 2019-03-31 | ₹1.06 Billion | ₹299.93 Million | 0.282x | +211.71% |
| 2018-03-31 | ₹884.08 Million | ₹80.00 Million | 0.090x | -63.89% |
| 2017-03-31 | ₹808.34 Million | ₹202.60 Million | 0.251x | -11.86% |
| 2016-03-31 | ₹691.28 Million | ₹196.59 Million | 0.284x | -- |